Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
Category & Conditions: Cancer
Study Phase : 1
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: English
ViewDownloadPrint
Farmacokinetisch onderzoek naar de geneesmiddeleninteractie van probegeneesmiddelen die met encorafenib en binimetinib zijn toegediend bij patiënten met melanoom of andere gevorderde solide tumoren waarbij sprake is van een BRAF V600-mutatie
Category & Conditions: Cancer
Study Phase : 1
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: Dutch
ViewDownloadPrint
Étude pharmacocinétique des interactions médicamenteuses entre l’encorafénib et le binimétinib sur des substrats tests chez des patients atteints d’un mélanome ou d’autres tumeurs solides avancées avec mutation BRAF V600
Category & Conditions: Cancer
Study Phase : 1
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: French
ViewDownloadPrint
Pharmakokinetische Studie zu Arzneimittelwechselwirkungen von Encorafenib und Binimetinib mit Prüfmedikamenten bei Patienten mit Melanomen mit BRAF-V600- Mutation oder anderen soliden Tumoren im fortgeschrittenen Stadium
Category & Conditions: Cancer
Study Phase : 1
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: German
ViewDownloadPrint
Estudio farmacocinético de las interacciones farmacológicas de encorafenib y binimetinib con fármacos sonda en pacientes con melanoma u otros tumores sólidos con mutación de BRAF V600
Category & Conditions: Cancer
Study Phase : 1
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: Spanish
ViewDownloadPrint
Encorafenib and Binimetinib in Combination With Targeted Third Agents in Advanced BRAF Melanoma (LOGIC-2)
Category & Conditions: Cancer
Study Phase : 2
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: English
ViewDownloadPrint
A Study of Encorafenib + Binimetinib in Patients With BRAF V600-mutant Non-Small Cell Lung Cancer
Category & Conditions: Cancer
Study Phase : 2
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: English
ViewDownloadPrint
A Study Comparing Combination of Encorafenib + Binimetinib as a Standard-dose and a High-dose Regimen in Patients with BRAFV600-Mutant Melanoma Brain Metastasis
Category & Conditions: Cancer
Study Phase : 2
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: English
ViewDownloadPrint
Encorafenib en Binimetinib in combinatie met derde doelgerichte middelen bij gevorderd BRAF-melanoom (LOGIC-2)
Category & Conditions: Cancer
Study Phase : 2
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: Dutch
ViewDownloadPrint
Binimetinib, Encorafenib, And Cetuximab Combined to Treat BRAF-mutant ColoRectal Cancer
Category & Conditions: Cancer
Study Phase : 3
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: English
ViewDownloadPrint
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma
Category & Conditions: Cancer
Study Phase : 3
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: English
ViewDownloadPrint
Een fase Ib/II studie naar LGX818 in combinatie met MEK162 onder volwassen patiënten met BRAF-afhankelijke gevorderde solide tumoren
Category & Conditions: Cancer
Study Phase : 1/2
Medicine: Braftovi (encorafinib) + Mektovi (binimetinib)
Language: Dutch
ViewDownloadPrint